Most Pioneering Microorganism Identification Solutions Provider 2025
Microbira are are delighted to share that Mcirobira has been recognised as the ‘Most Pioneering Microorganism Identification Solutions Provider 2025.’ The SME news article about the UK Enterprise Awards can be read by clicking the link above. The full list of winners is also available to view. This award highlights our commitment to innovation in microbial diagnostics and our mission to improve global healthcare outcomes.
Transforming Microbial Identification
At Microbira, we are revolutionising micro-organism identification. We developed the Microbira Advanced Analytical Platform – Infrared (MAAP-IR) as our flagship technology. It utilises Fourier Transform Infrared (FTIR) spectroscopy and artificial intelligence (AI) to deliver fast, reagent-free, and cost-effective diagnostic solutions.
Unlike traditional culture methods that can take more than 24-28 hours, MAAP-IR provides accurate microorganism identification in under 5 minutes. This enables healthcare professionals to make faster, more effective treatment decisions.
Driving Global Healthcare Impact
Founded in 2019, Microbira’s goal is to make advanced diadnostics accessible worldwide. Validated through collaborations witht the NHS and research partners, MAAP-IR can help laboratories improve patient outcomes, reduce healthcare disparities, increase sustainability and streamline workflows.
We are currently expanding into the Indian market, which allows us to continue to deliver an affordable, scalable and sustainable solution to healthcare providers and researchers.
A Proud Milestone
This SME award is a testament to our talented team’s hard work and our dedication to advancing microbiral diagnostics. We proudly recognise our pioneering technology for its potential to create a positive impact on global healthcare.
Stay tuned by following us on LinkedIn as we continue to innovate and provide cutting-edge diagnostic solutions for healthcare providers and research labs worldwide.
